Pinpointing the Top Questions about Biosimilars in Rheumatology

Faculty

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic & Rheumatologic Institute
Cleveland Clinic
Cleveland, Ohio

John R. Tesser, MD
Adjunct Assistant Professor
Division of Clinical Education
Midwestern University, Arizona College of Osteopathic Medicine
Glendale, Arizona
Arizona Arthritis & Rheumatology Associates
Phoenix, Arizona 

MOC REVIEWERS

Theodore Bruno, MD
Chief Medical Officer
The France Foundation
Old Lyme, Connecticut 

Cassandra M. Calabrese, DO
Fellow – Rheumatology and Infectious Disease
Cleveland Clinic
Cleveland, Ohio 

Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, The France Foundation (TFF) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosures-Content Creators/Activity Faculty

The following faculty report that they have relevant financial relationships to disclose:

• Leonard H. Calabrese, DO, has served as a consultant for AbbVie, Bristol Myers-Squibb, Centocor Biotech, Genentech, GSK, Horizon, Janssen and Pfizer. He has received honoraria from Crescendo Bioscience.
• John R. Tesser, MD, has served as a consultant for Amgen, Bristol-Myers Squibb, Crescendo Biosciences/Mallinkrodt, Genentech, Janssen, Lilly, Medac, Pfizer, Sanofi-Genzyme/Regeneron and UCB. He has served on a speaker’s bureau for AbbVie, Amgen, Bristol Myers-Squibb, Crescendo Bioscience, Genentech, Janssen, Lilly, Medac, Pfizer and UCB. He has received research grants or support from AbbVie, Ablynx, Amgen, AstraZeneca, Bristol Myers-Squibb, Boehringer Ingelheim Pharmaceuticals, Inc, Celgene, Genentech, GSK, Janssen, Lilly, Merck KG, Novartis, Pfizer, Sandiz, Sun Pharma, and UCB.

MOC Reviewer Disclosures

The faculty listed below report that they have no relevant financial relationships to disclose:

• Theodore Bruno, MD
• Cassandra M. Calabrese, DO

DISCLOSURE OF UNLABELED USE

TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.